Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip

Name: Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip
Published: 2009
License: Public Domain

Pfizer · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

arthritis monoclonal-antibody osteoarthritis

osteoarthritis, arthritis, monoclonal antibody, nerve growth factor (ngf), anti-ngf, tanezumab, pf-04383119, rn624, osteoarthritis (oa), interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip

Related documents